LRI Investments’s ANI Pharmaceuticals ANIP Stock Holding History

LRI Investments’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.3K	Sell	52 -26	-33%	-$2.09K	﹤0.01%	1170
2026 Q1	$6K	Hold	78	–	–	﹤0.01%	1034
2025 Q4	$6.19K	Buy	78 +12	+18%	+$1.04K	﹤0.01%	994
2025 Q3	$6.01K	Hold	66	–	–	﹤0.01%	1002
2025 Q2	$4.28K	Hold	66	–	–	﹤0.01%	1053
2025 Q1	$4.39K	Hold	66	–	–	﹤0.01%	980
2024 Q4	$3.63K	Hold	66	–	–	﹤0.01%	990
2024 Q3	$3.87K	Buy	+66	New	+$4.03K	﹤0.01%	982

Other funds holding ANIP

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $679M AUM 47.51% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Ares Financial Consulting Calabasas, California $139M AUM